What drove ALNEV.PA stock higher after hours today?

Heavy trading of **32,488,147** shares and a tight float drove ALNEV.PA stock to **€0.0012** after hours; microcap flows and speculative buying can move the price sharply without company news.

How does Meyka AI view ALNEV.PA stock from a ratings perspective?

Meyka AI rates ALNEV.PA **62.23/100 (B, HOLD)** based on benchmarks, sector data, financial growth and forecasts; external ratings note a **C- Strong Sell** which emphasises model variance.

What is the short‑term forecast for ALNEV.PA stock?

Meyka AI's forecast model projects **€0.04** monthly for ALNEV.PA stock, implying **~3233.33%** upside from **€0.0012**, but forecasts are projections and not guarantees.

What are the main risks for ALNEV.PA stock holders?

Primary risks are clinical trial failure, equity dilution, regulatory setbacks, and extreme liquidity sensitivity due to a **€572.00** market cap and thin public float.

EU Stocks

ALNEV.PA Neovacs (EURONEXT) €0.0012 after-hours, high volume: what investors watch 10 Mar 2026

ByHuzaifa Zahoor March 10, 2026March 10, 2026

ALNEV.PA stock moved higher in after-hours trading on 10 Mar 2026 to €0.0012, up 9.09% on a heavy 32,488,147 share print. This spike makes Neovacs S.A. (ALNEV.PA) one of the most active names on EURONEXT in Europe after the close. The move reflects very thin market capitalisation (€572.00) and extreme price sensitivity to any news or trading flows. We review liquidity, fundamentals, technicals, a proprietary Meyka grade, and a model forecast to put this level in context for traders and longer-term observers.